New cocktail of drugs shows promise for stomach cancer patients
Disease control
Not yet recruiting
This phase 2 trial tests a combination of four drugs—mannatide, two chemotherapy drugs, and an immunotherapy—as a first treatment for people with advanced stomach or gastroesophageal junction cancer that has spread or come back. The study will enroll 52 participants to see if the…
Phase: PHASE2 • Sponsor: Ming Liu • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC